Navigation Links
Mechanism that may trigger degenerative disease identified
Date:6/25/2010

A mechanism that regulates stem-cell differentiation in mice testes suggests a similar process that may trigger degenerative disease in humans, according to a Penn State College of Agricultural Sciences reproductive physiologist.

Research involved manipulating a protein called STAT3 that signals stem cells to decide whether to differentiate into a specialized type of cell or self-renew and remain stem cells. By manipulating STAT3, researchers identified a key regulator of spermatogonial stem cell self-renewal.

The STAT3 protein, which is active in tissues throughout the body and is essential for life, regulates genes that are involved in cell growth and division, cell movement, and the self-destruction of cells. All tissue and organs within the body are based on a specific differentiated cell type, and these cells are constantly lost through cell death and aging. For the testis, the differentiated cell type is sperm.

Every time a stem cell divides, it produces two new cells. Self-renewal is the process by which this division results in a stem cell duplicating itself, thus maintaining a stem cell pool. Differentiation is when the stem cell division produces cells that will become the differentiated cells that maintain the function of the tissue or organ. Impairment of either of these stem-cell functions manifests as tissue and organ failure, so deciphering the mechanisms that regulate stem-cell activity is of utmost importance for devising treatments for degenerative diseases.

"We looked at a mechanism that is involved in the differentiation of stem cells, and we were actually able to shift that decision away from differentiation into self-renewal," said Jon Oatley, assistant professor of reproductive physiology, who led the study. "Right now we are at the ground level -- we discovered this in a mouse, and we hope we can start to look at it in human disease to see whether this pathway still holds true. We hope that down the line, as we study it further, we may be able to tie it to human disease."

Several key regulators of spermatogonial stem cell self-renewal have been identified, but knowledge of molecules that control spermatogonial stem cell differentiation is lacking, Oatley explained.

"In this study, we found that impairment of STAT3 signaling enhances spermatogonial stem cell self-renewal without affecting general proliferation of the cells. That indicates an alteration in the balance of spermatogonial stem cell fate decisions that inhibited differentiation in favor of self-renewal."

Much stem-cell research is done of necessity with mice, noted Oatley, who pointed out that scientists who use the mouse as a model for human biology make the assumption that what they learn about in a mouse is identical to what happens in a human.

"Ideally, any of us who work with mice would love to translate our work into humans, but the problem is that you can't get the tissue samples from humans, and you can't manipulate the genetics of humans to show what we want to learn," he said.

Oatley said he believes his research is a solid first step in helping scientists learn how to regulate STAT2 levels to treat or control degenerative disease in humans.


'/>"/>

Contact: A'ndrea Elyse Messer
aem1@psu.edu
814-865-9481
Penn State
Source:Eurekalert

Related medicine news :

1. Study identifies 1 of the mechanisms behind breast cancer metastasis
2. Pancreatic cancer study reveals mechanism initiating disease, in mice
3. Pancreatic Cancer Study Reveals Mechanism Initiating Disease, In Mice
4. Multiple sclerosis, Italian researchers discover a possible onset mechanism for the disease
5. Tumor mechanism identified
6. UCR researcher identifies mechanism malaria parasite uses to spread in red blood cells
7. IU research team discovers TB disease mechanism and molecule to block it
8. Discovery of mechanism in brain cell injury in Huntingtons offers new treatment approaches
9. Scientists uncover protective mechanism against liver cancer
10. Mechanism discovered by which bodys cells encourage tuberculosis infection
11. Newly discovered mechanism by which blood clots form
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... ... ProText Layouts is a set of 30 self-animating kinetic text layouts created ... video editors can create an energetic typography video with incredible ease. Utilize intuitive ... text-based videos have never been easier. , ProText Layouts includes 30 kinetic text layouts ...
(Date:4/28/2016)... ... April 28, 2016 , ... University of New England President Danielle N. ... vice president of Student Engagement. In addition to his role as director of ... areas. , “In the space of just one year Jack has distinguished himself ...
(Date:4/28/2016)... D.C., (PRWEB) , ... April 28, 2016 , ... ... systems, and the Campaign for Tobacco-Free Kids, a leading force in the fight ... promote federal, state and local policies that can help reduce tobacco use. The ...
(Date:4/28/2016)... ... 2016 , ... Horizon Blue Cross Blue Shield of New ... make transformative changes in how health care is delivered and financed in New ... breakthroughs in cellular medicine to treat disease. After accepting an invitation to speak ...
(Date:4/28/2016)... ... April 28, 2016 , ... Amada Senior Care, premier provider of ... San Antonio – its San Antonio West location. Prior to entering the senior care ... The grand opening of Amada San Antonio West will take place on Friday, April ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... NEW YORK , April 28, 2016 ... of online consumer insights on healthcare, announced today that ... in their report Cool Vendor in Life Sciences, ... , April 15, 2016.  The report focuses on life-science- ... to gain insight from patients and doctors, confirm medication ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ... on the development of oral drug delivery systems, announced today ... conference, presented by Joseph Gunnar & Co. LLC, ... York . Nadav Kidron , CEO of Oramed, ... Presentation Details:   PIONEERS 2016, presented by ...
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
Breaking Medicine Technology: